Jonathan in the Patient Services team discusses recent research into the use of cell therapies to treat Graft versus Host Disease (GvHD), which is a common side effect of stem cell transplant. He also looks at the implications this may have for patients whose symptoms have not responded to standard treatments. Graft vs Host…
A healthy gut We have known for a long time that our digestive system is home to billions of tiny microbes that help us digest our food properly. We are even encouraged to look after them by drinking “pro-biotic” products that we are told will aid our digestion. But recent research has shown that bacteria…
On 6 January George Freeman, Life Sciences Minister visited our Research Institute to launch our new Third Generation Sequencing technology (TGS), which will improve stem cell transplant outcomes and make the best patient-donor matches ever.
With the help of our colleagues at Be The Match in the U.S., we’ve collated the latest news from the world of stem cell transplant research.
Read on to learn about treatment options for older people with acute myeloid leukaemia, a new drug with potential for treating GvHD, and new studies on haploidentical transplantation.
With the help of our colleagues at Be The Match in the U.S., here’s the latest news from the world of stem cell transplant research.
Our research team is always taking on groundbreaking new initiatives to improve transplantation and quality of life for patients.
And that’s why we asked one of our PhD-student researchers, Vikesh Devlia, to write about his new study of how long it takes the immune system to regenerate in patients who’ve had a cord blood transplant.